Uncovering new approaches to target FOXR2 in pediatric cancers |
Children’s Hospital Los Angeles / Jessica Tsai, MD/PhD |
'A' Award Grants |
2024 |
California |
Targeting Novel Inflammatory Signaling Pathways in Juvenile Myelomonocytic Leukemia |
Indiana University / Santhosh Kumar Pasupuleti, PhD |
'A' Award Grants |
2024 |
Indiana |
Collective cell invasion of fusion positive rhabdomyosarcoma regulated by PAX3-FOXO1 |
Children’s Hospital Los Angeles / Jinseok Park, PhD |
'A' Award Grants |
2024 |
California |
Gene-mediated cytotoxic immunotherapy in pediatric patients with recurrent malignant brain tumors |
University of Michigan / Andrea Franson, MD |
'A' Award Grants |
2024 |
Michigan |
Exploring the Interplay of Microbiome, Bile Acids, Immune Reconstitution, and Clinical Outcomes Following Allogeneic Hematopoietic Transplantation in Pediatrics |
Memorial Sloan-Kettering Cancer Center / Oriana Miltiadous, MD |
Reach Grants |
2024 |
New York |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic |
Baylor College of Medicine / Robin Parihar, MD/PhD |
Reach Grants |
2024 |
Texas |
IGFBPL1 Peptide-Centric Chimeric Antigen Receptor Autologous T Cells for Relapsed HLA-A*02 Neuroblastoma and Medulloblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2024 |
Pennsylvania |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic |
Baylor College of Medicine / Robin Parihar |
Reach Grants |
2024 |
Texas |
Overcoming Menin-inhibitor resistance
|
Children’s Hospital of Philadelphia / Kathrin Bernt, MD |
Reach Grants |
2024 |
Pennsylvania |
Therapeutic targeting of clonal hematopoiesis in RUNX1 mutant FPDMM |
University of Pennsylvania / Robert Bowman, Ph.D. |
RARE Grant Program (Research Accelerating RUNX1 Exploration) |
2024 |
Pennsylvania |